Literature DB >> 15570194

Genotype and allele frequencies of C3435T polymorphism of the MDR1 gene in various Jewish populations of Israel.

Olga Ostrovsky1, Arnon Nagler, Michael Korostishevsky, Ephraim Gazit, Hanan Galski.   

Abstract

The human multidrug-resistant gene (MDR1) encodes for P-glycoprotein (P-gp), which is a membrane-bound efflux-transporter conferring resistance to a number of natural cytotoxic drugs and potentially toxic xenobiotics. The wobble C3435T polymorphism at exon 26 was associated with different expression levels of the MDR1 gene and substrate uptake. Differences in allele frequencies of the C3435T polymorphism have previously been demonstrated between racial groups. In this study, 500 individuals from 5 Jewish populations of Israel (Ashkenazi, Yemenite, North African, Mediterranean, Near-Eastern) were examined for C3435T polymorphism using a PCR-RFLP-based technique to calculate genotype and allele frequencies. Frequencies of the C allele were quite similar among the Ashkenazi (0.65), Yemenite (0.645), and North-African (0.615) Jewish populations. However, the frequency of this allele was slightly lower among Mediterranean Jews (0.58) and significantly lower among Near-Eastern Jews (0.445). The frequency of the C allele among Near-Eastern Jews is, therefore, significantly different from those of all other tested Jewish populations. In comparison to previously studied non-Jewish populations, the frequency of this allele among Near-Eastern Jews is different from that in West Africans (0.91) but is similar to that in whites (0.497). However, the C allele frequencies among the other 4 Jewish populations are significantly lower than that found among West Africans and significantly higher than among non-Jewish whites. These data may have important therapeutic and prognostic implication for P-gp-related drug dosage recommendation in Jewish populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570194     DOI: 10.1097/00007691-200412000-00015

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

1.  A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation.

Authors:  Sherwin K B Sy; Jules Heuberger; Sireen Shilbayeh; Daniela J Conrado; Hartmut Derendorf
Journal:  AAPS J       Date:  2013-08-30       Impact factor: 4.009

Review 2.  Genetic diversity and new therapeutic concepts.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

3.  Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.

Authors:  Chava Kimchi-Sarfaty; Andrew H Marple; Shiri Shinar; Avraham M Kimchi; David Scavo; M Isabella Roma; In-Wha Kim; Adam Jones; Mili Arora; John Gribar; David Gurwitz; Michael M Gottesman
Journal:  Pharmacogenomics       Date:  2007-01       Impact factor: 2.533

4.  ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

Authors:  Orna Levran; Kimberly O'Hara; Einat Peles; Dawei Li; Sandra Barral; Brenda Ray; Lisa Borg; Jurg Ott; Miriam Adelson; Mary Jeanne Kreek
Journal:  Hum Mol Genet       Date:  2008-04-17       Impact factor: 6.150

5.  Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey.

Authors:  Sebahat Turgut; Günfer Turgut; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2006-11-02       Impact factor: 2.742

6.  Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

Authors:  Nizar M Mhaidat; Osama Y Alshogran; Omar F Khabour; Karem H Alzoubi; Ismail I Matalka; William J Haddadin; Ibraheem O Mahasneh; Ahmad N Aldaher
Journal:  J Exp Clin Cancer Res       Date:  2011-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.